Help us: Donate
Follow us on:



Joe Betts-LaCroix at Ending Age-Related Diseases 2019

Joe Betts-LaCroix at Ending Age-Related Diseases 2019Joe Betts-LaCroix at Ending Age-Related Diseases 2019

We’re continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.

Joe Betts-LaCroix discussed the prioritization of aging compared to other government programs, the relationship between finance and human health, funding sources, and how YCombinator provides funding for startups. He went into detail about venture-funded startups in the biotechnology space, explaining their attitudes and culture, and explained how his company differs from this conventional model. Perhaps most critically to the in-person audience, he outlined what qualities a biotechnology startup needs to have before YCombinator considers funding it.

Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension: YouTube Facebook Twitter Instagram Instagram Discord
Thank You!

About the author
Josh Conway

Josh Conway

Josh is a professional editor and is responsible for editing our articles before they become available to the public as well as moderating our Discord server. He is also a programmer, long-time supporter of anti-aging medicine, and avid player of the strange game called “real life.” Living in the center of the northern prairie, Josh enjoys long bike rides before the blizzards hit.
No Comments
Write a comment:


Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.